A Texas resident has filed a GranuFlo lawsuit over a heart attack that he suffered allegedly as the result of the dialysis product during his dialysis treatment at a Fresenius medical facility in California. The complaint was filed in the US District Court, District of Massachusetts on April 1, 2015.... Read more »

A new testosterone therapy lawsuit has been filed by a Georgia couple over the heart attack suffered by the husband while he was taking Axiron, a testosterone replacement treatment produced by Eli Lilly. The complaint was filed by plaintiffs David T. Bowden and Judy Bowden of Polk County, GA on March... Read more »

An Axiron lawsuit has been filed over a heart attack death that plaintiffs contend was caused by testosterone replacement therapy. The complaint, filed on March 17 in the U.S. District Court for the Northern District of Illinois, Eastern Division, names Janice Ollenburger, individually and on behalf of Jerry Ollenburger, the... Read more »

Another Risperdal lawsuit over gynecomastia has been filed, this time in Louisiana. Karon-Jahlil Williams v. Janssen Pharmaceuticals, Inc., Johnson & Johnson, and Janssen Research and Development, L.L.C. (Case # 5:14-cv-03354) was filed on December 2, 2014 in the US. District Court for the Western District of Louisiana (Shreveport Division). The... Read more »

A motion to establish a multidistrict litigation (MDL) encompassing a growing number of Xarelto bleeding injury lawsuits will be heard on December 4 before the U.S. Judicial Panel on Multidistrict Litigation. The judges who are part of the panel will consider the merits of forming the MDL as a response... Read more »

A talcum powder lawsuit filed by 65 women has been remanded, returning it to the Circuit Court of St. Louis, Missouri. Judge Jean C. Hamilton issued the order on September 24, indicating that the defendants in the case, Johnson & Johnson, had wrongly removed the case to federal court. The... Read more »

Amid concerns over testosterone therapy side effects, an FDA panel has backed limitations on labeling for testosterone to exclude prescriptions for men who take the therapy only to counteract ordinary signs of aging rather than specific hormonal abnormalities. The panel also voted overwhelmingly to require clinical safety trials for some... Read more »

The judge in one of the early Actos bladder cancer trials has upheld a record-breaking $9 billion punitive damages award against Takeda Pharmaceuticals and Eli Lilly, who recently attempted to have the Actos lawsuit award thrown out. U.S. District Judge Rebecca Doherty ruled that the jurors who assigned the award... Read more »

In the wake of an Actos bladder cancer lawsuit verdict in April of this year, Takeda Pharmaceuticals and its U.S. partner Eli Lilly are now seeking a new trial or a reversal of the judgment, which includes both $1.5 million in compensatory damages for the plaintiff and a combined $9... Read more »